We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$737M
AUM Growth
-$15.3M
Cap. Flow
-$5.45M
Cap. Flow %
-0.74%
Top 10 Hldgs %
24.74%
Holding
518
New
2
Increased
5
Reduced
1
Closed
14

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$1.11M
2
SPHR icon
Sphere Entertainment
SPHR
+$245K
3
NSLR
Neostellar Capital Corp
NSLR
+$23.5K
4
DHR icon
Danaher
DHR
+$272
5
GE icon
GE Aerospace
GE
+$64

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.65M
2
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$1.1M
3
NAV
Navistar International
NAV
+$623K
4
QTS
QTS REALTY TRUST, INC.
QTS
+$618K
5
MSFT icon
Microsoft
MSFT
+$495K

Sector Composition

Rank Sector Weight
1 Technology 24.79%
2 Financials 14.06%
3 Healthcare 12.76%
4 Industrials 11.98%
5 Communication Services 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBRA icon
476
Sabra Healthcare REIT
SBRA
$5.37B
$172K 0.02%
11,703
– –
VNTR
477
DELISTED
Venator Materials PLC
VNTR
$171K 0.02%
60,000
– –
GNL icon
478
Global Net Lease
GNL
$1.92B
$167K 0.02%
10,400
– –
FOLD
479
DELISTED
Amicus Therapeutics
FOLD
$162K 0.02%
17,000
– –
EVC icon
480
Entravision Communication
EVC
$1.1B
$156K 0.02%
22,000
– –
PVLA
481
Palvella Therapeutics
PVLA
$2.27B
$155K 0.02%
375
– –
CTEK
482
DELISTED
CynergisTek, Inc.
CTEK
$155K 0.02%
86,000
– –
KYNB
483
Kyntra Bio
KYNB
$29.1M
$153K 0.02%
600
– –
FTI icon
484
TechnipFMC
FTI
$27.3B
$151K 0.02%
20,000
– –
NXGN
485
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$141K 0.02%
10,000
– –
WTTR icon
486
Select Water Solutions
WTTR
$2.87B
$140K 0.02%
27,000
– –
ACTG icon
487
Acacia Research
ACTG
$463M
$136K 0.02%
20,000
– –
BRSP
488
BrightSpire Capital
BRSP
$652M
$131K 0.02%
14,000
– –
SNCR
489
DELISTED
Synchronoss Technologies
SNCR
$130K 0.02%
6,000
– –
ESPR
490
DELISTED
Esperion Therapeutics
ESPR
$122K 0.02%
10,125
– –
NCMI icon
491
National CineMedia
NCMI
$377M
$110K 0.01%
3,100
– –
HIL
492
DELISTED
Hill International, Inc. Common Stock
HIL
$104K 0.01%
50,000
– –
BHR
493
Braemar Hotels & Resorts
BHR
$141M
$103K 0.01%
21,300
– –
PGEN icon
494
Precigen
PGEN
$2.52B
$75K 0.01%
15,000
– –
TUSK icon
495
Mammoth Energy Services
TUSK
$166M
$70K 0.01%
24,000
– –
RDI icon
496
Reading International Class A
RDI
$34.5M
$68K 0.01%
13,500
– –
EMWP
497
DELISTED
Eros Media World PLC
EMWP
$60K 0.01%
3,250
– –
AUD
498
DELISTED
Audacy, Inc.
AUD
$59K 0.01%
16,000
– –
CLVS
499
DELISTED
Clovis Oncology, Inc.
CLVS
$58K 0.01%
13,000
– –
WVE icon
500
Wave Life Sciences
WVE
$1.17B
$57K 0.01%
11,700
– –
17 18 19
20
21

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q3 2021 Portfolio in Review

As of Q3 2021, NJ State Employees Deferred Compensation Plan held 518 positions worth $737M, down 2% from $752M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 3.1%. NJ State Employees Deferred Compensation Plan opened 2 new positions and exited 14, leaving the 518-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q3 2021 buy was AstraZeneca: 9,560 shares worth $1.15M.
  • NJ State Employees Deferred Compensation Plan added most to Neostellar Capital Corp in Q3 2021, an estimated $23.5K increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q3 2021 reduction was Microsoft, cutting an estimated $495K.
  • NJ State Employees Deferred Compensation Plan fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.65M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 25% of its $737M portfolio in Q3 2021.
  • NJ State Employees Deferred Compensation Plan opened 2 new positions and closed 14 in Q3 2021.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 2% quarter-over-quarter to $737M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2021, filed 26 Oct 2021.